Spotlight
Featured
Harley Street Health District together with AlbionVC to accelerate access to breakthrough healthcare technologies
EpilepsyGTx raises $33m Series A to develop single dose gene therapy for focal refractory epilepsy
Scripta Tx raises $12m to develop disease-modifying transcription therapies
Scripta Tx raises $12m to develop disease-modifying transcription therapies
Breakthrough gene therapy transforms teenager's life | The Times
Breakthrough gene therapy transforms teenager’s life
AlbionVC: London still outpaces Paris in tech | UKTN
Ed Lascelles, AlbionVC Partner shares insights on the State of European Tech: Why London Still Leads
Universities should not be greedy with technology spin-offs | FT
Dave Grimm, Partner at AlbionVC, chats to John Gapper, Financial Times, on the opportunities that commercialising research presents, on the back of our very successful partnership with UCL.
UK universities take record low spinout stakes: ‘But that’s only half the battle’
David Grimm, Partner AlbionVC discusses university spinout terms and timelines with Sifted
Today, 90% of Russell Group universities have affiliated funds as reported by Sifted
Why We’re Bullish on London University Spinouts
HTBC Techbio Sess. 3: exploring the business strategies powering the techbio revolution
Reflection on HTBC Techbio Session 3
Simon Goldman on transforming hard science into global impact – Podcast
